In search for new antipsoriatic agents: NAD topical composition

Skin Pharmacology and Physiology

Volumn 20, Issue 1, 2006, Pages 37-42

  Wozniacka, A ^a   Szajerski, P ^b   Adamus, J ^b   Gebicki, J ^b   Sysa Jedrzejowska, A ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Antipsoriatic therapy; Nicotinamide adenine dinucleotide; Psoriasis

Indexed keywords

ANTIPSORIASIS AGENT; DITHRANOL; EMOLLIENT AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECOMPOSITION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; ENZYME CHEMISTRY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS; ROOM TEMPERATURE; SKIN DISCOLORATION;

ADMINISTRATION, TOPICAL; ADULT; ANTHRALIN; CHEMISTRY, PHARMACEUTICAL; DERMATOLOGIC AGENTS; DRUG STABILITY; FEMALE; HUMANS; MALE; MIDDLE AGED; NAD; OINTMENTS; PSORIASIS;

EID: 33845804743     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096170     Document Type: Article

References (24)

1. Ashcroft DM, Li Wan Po A, Griffiths CE: Therapeutic strategies for psoriasis. J Clin Pharm Therap 2000;25:1-10.
2. Müller K: Antipsoriatic and proinflammatory action of anthralin. Biochem Pharmacol 1997;53:1225-1221.
3. Fogh K, Kragballe K: Recent developments in vitamin D analogs. Curr Pharm Design 2000;6:961-972.
4. Brown JR, Cornell K, Cook PW: Adenosine-and adenine-nucleotide-mediated inhibition of normal and transformed keratinocyte proliferation is dependent upon dipyridamole-sensitive adenosine transport. J Invest Dermatol 2000;115:849-859.
5. Levi-Schaffer F, Touitou E: Xanthines Inhibit 3T3 fibroblast proliferation. Skin Pharmacol 1991;4:286-290.
6. Levi-Schaffer F, Dayan N, Touitou E: Diethylene glycol monoethyl ether (Transcutol) displays antiproliferative properties alone and in combination with xanthines. Skin Pharmacol 1996;9:53-59.
7. Iancu I: Experimental treatment of psoriasis with compounds which increase the intracellular level of cAMP; thesis, Tel Aviv University, 1979.
8. Kim UH, Han MK, Park BH, Kim HR, An NH: Function of NAD glycohydrolase in ADP-ribose uptake from NAD by human erythrocytes. Biochim Biophys Acta 1993;1178:121-126.
9. + into a calcium-mobilizing metabolite. Cell Regul 1991;2:203-209.
10. Travo P, Muller H, Shuber F: Calf spleen NAD glycohydrolase. Comparison of the catalytic properties of the membrane-bound and the hydrosoluble forms of the enzyme. Eur J Biochem 1979;96:141-149.
11. Zimmermann H: Extracellular purine metabolism. Drug Dev Res 1996;39:337-352.
12. Aleo MF, Sestini S, Pompuci G, Preti A: Enzymatic activities affecting exogenous nicotinamide adenine dinucleotide in human skin fibroblasts. J Cell Physiol 1996;167:173-176.
13. Aleo MF, Gindici ML, Sestini S, Pompuci G, Preti A: Metabolic fate of extracellular NAD in human skin fibroblasts. J Cell Biochem 2001;80:360-366.
14. Gȩbicki J, Marcinek A, Adamus J, Paneth P, Rogowski J: Structural aspects and rearrangement of radical cations generated from NADH analogues. J Am Chem Soc 1996;118:691-692.
15. +. Acc Chem Res 2004;37:379-386.
16. Marcinek A, Adamus J, Huben K, Gȩbicki J, Bartczak TJ, Bednarek P, Bally T: Hydrogen-transferred radical cations of NADH model compounds. 1. Spontaneous tautomerization. J Am Chem Soc 2000;122:437-443.
17. Wozniacka A, Sysa-Jȩdrzejowska A, Adamus J, Gȩbicki J: Topical application of NADH for the treatment of rosacea and contact dermatitis. Clin Exp Dermatol 2003;28:61-63.
18. Ganti T, Fodor J: Studies on the kinetics of NAD-decomposition. Acta Physiol Acad Sci Hung 1965;26:199-205.
19. Lawry OH, Passonneau JV, Rock MK: The stability of pyridine nucleotides. J Biol Chem 1961;236:2756-2759.
20. Braun-Falco O, Plewig G, Wolf HH, Burgdorf WHC: Dermatology. Heidelberg, Springer, 2000, p 597.
21. Unna PG: Cignolin als Heilmittel der Psoriasis. Dermatol Wochenschr 1916;62:116-137.
22. Griffiths CE, Camp RD, Barker JN: Psoriasis; in Burns T, Breathnach S, Cox N, Griffiths C (eds): Rook's Textbook of Dermatology. Oxford, Blackwell Science, 2004, pp 35.1-35.69.
23. Lowe NJ, Breeding J: Anthralin. Different concentration effects on epidermal cell DNA synthesis rates in mice and clinical responses in human psoriasis. Arch Dermatol 1981;117:698-700.
24. Montes LF, Wilborn WH, Brody I: Low strength anthralin in psoriasis. J Cutan Pathol 1979;6:445-456.